Thank you, Lisa, and thanks for joining us. The biopharmaceutical and Diagnostic Solutions segment delivered another solid ...
Q4 2025 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsNick Lynton - Chief Legal & Privacy Officer and ...
Q4 2025 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsKyle Pilkington - Chief Legal OfficerQichao Hu - ...
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced the launch of AgentSCREEN ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...
Exploring the overlooked aspects of substance-related sexuality, a new analysis of young adults demonstrates how cannabis serves to heighten physical pleasure and intimacy.
Explore how clinical multi-omics integration drives systems medicine, detailing data fusion methodologies and lab ...
Background Data-sharing mandates from funders and journals have increased in recent years, but little is known about how shared data are used. Existing research has focused on access frameworks, with ...
Why do so many workplace frustrations in veterinary medicine feel hard to explain? Building on last week’s episode of The Resilient Vet: Mind and Body Strategies for Success, hosts Aaron Shaw, OTR/L, ...
Corporate broadcast networks again reduced climate coverage in 2025, marking the third year coverage has declined since the networks' high-water mark of 23 hours of reporting in 2022. A Media Matters ...
The origin of the nucleus remains hotly debated among scientists, but new imaging and genomic data are shedding light on this billion-year-old mystery.
Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...